SEC Info - Paratek Pharmaceuticals, Inc. - ‘S-4MEF’ on 10/27/14

SEC Info℠

Home

Help

Please Sign In

Paratek Pharmaceuticals, Inc. – ‘S-4MEF’ on 10/27/14 – ‘EX-99.5’

On: Monday, 10/27/14, at 8:58pm ET · Effective: 10/27/14 · Accession #: 1193125-14-383742 · File #s: 333-198464, 333-199624

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

10/27/14  Paratek Pharmaceuticals, Inc.     S-4MEF     10/27/14   12:143K                                   Donnelley … Solutions/FA

Registration of Additional Securities — Form S-4
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: S-4MEF      Registration of Additional Securities               HTML     44K 
 2: EX-5.1      Opinion re: Legality                                HTML     18K 
 3: EX-8.1      Opinion re: Tax Matters                             HTML     22K 
 4: EX-8.2      Opinion re: Tax Matters                             HTML     18K 
 5: EX-23.1     Consent of Experts or Counsel                       HTML      7K 
 6: EX-23.2     Consent of Experts or Counsel                       HTML      8K 
 7: EX-99.1     Miscellaneous Exhibit                               HTML      7K 
 8: EX-99.2     Miscellaneous Exhibit                               HTML      8K 
 9: EX-99.3     Miscellaneous Exhibit                               HTML      8K 
10: EX-99.4     Miscellaneous Exhibit                               HTML      8K 
11: EX-99.5     Miscellaneous Exhibit                               HTML      8K 
12: EX-99.6     Miscellaneous Exhibit                               HTML      8K

EX-99.5 — Miscellaneous Exhibit

This Exhibit is an HTML Document rendered as filed. [ Alternative Formats ]

EX-99.5

Exhibit 99.5

October 27, 2014

Transcept Pharmaceuticals, Inc.

1003 W. Cutting Blvd., Suite #110

Point Richmond, CA 94804

Consent to Reference in Proxy Statement/Prospectus/Information Statement

Transcept Pharmaceuticals, Inc. (the “Company”) is filing a Registration Statement on Form S-4 (Registration No. 333- ) with the Securities and Exchange Commission under the Securities Act of 1933, as amended (the “Securities Act”). In connection therewith, I hereby consent, pursuant to Rule 438 of the Securities Act, to the reference to me in the proxy statement/prospectus/information statement included in such registration statement as a future member of the board of directors of the Company.

Sincerely,

/s/ Richard J. Lim

Name: Richard J. Lim

Dates Referenced Herein

This ‘S-4MEF’ Filing	Date	Other Filings

Filed on / Effective on:	10/27/14	None on these Dates
		List all Filings

↑Top